HEPAREGENIX
HQ - Tübingen
Summary
HepaRegeniX is a clinical stage company developing a novel regenerative therapy for the treatment of acute and chronic liver diseases
Deals Overview
Total Dealss1
Valued Deals1
Total Value£ 13 M
Avg. Deal Size£ 13 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
